Health Care & Life Sciences » Healthcare Provision | PureTech Health PLC

PureTech Health PLC | Income Statement

Fiscal year is January-December. All values GBP Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
5,439.90
1,349.50
7,741.80
3,283.90
1,968.40
15,560.20
Cost of Goods Sold (COGS) incl. D&A
289.80
-
-
-
-
-
Gross Income
5,150.00
-
-
-
-
-
SG&A Expense
7,123.70
11,706.20
35,822.70
56,911.00
89,468.10
91,486.90
EBIT
1,973.70
10,594.80
28,565.20
54,790.60
89,129.60
78,010.10
Unusual Expense
466.40
34,235.70
6,129.70
2,759.20
56,211.20
40,947.80
Non Operating Income/Expense
745.30
86.90
507.30
63.00
110,677.60
2,939.10
Interest Expense
234.80
1,575.40
2,847.20
5,045.60
7,930.40
11,103.90
Pretax Income
3,397.10
46,291.10
36,863.40
61,648.30
41,234.70
42,708.70
Income Tax
175.30
168.80
1,259.30
1,166.50
10.90
1,665.70
Equity in Affiliates
-
-
-
-
13,672.70
8,617
Consolidated Net Income
3,572.40
46,122.30
38,122.70
60,481.70
54,896.60
52,991.40
Net Income
3,048.40
25,291.00
25,784.10
36,161.00
23,969.90
32,738.80
Net Income After Extraordinaries
3,344.00
25,291.00
25,784.10
36,161.00
23,969.90
32,738.80
Net Income Available to Common
2,752.90
25,291.00
25,784.10
36,161.00
23,969.90
32,738.80
EPS (Basic)
0.04
0.31
0.14
0.16
0.10
0.12
Basic Shares Outstanding
63,639.40
82,453.40
185,281.20
229,511.90
235,532.40
273,848.30
EPS (Diluted)
0.04
0.31
0.14
0.16
0.10
0.12
Diluted Shares Outstanding
63,639.40
82,453.40
185,281.20
229,511.90
238,921.30
273,848.30
EBITDA
1,683.80
10,356.80
28,080.80
53,627.10
87,499.70
75,926.70
Non-Operating Interest Income
23.00
27.90
171.50
884.20
1,358.90
2,518.40
Minority Interest Expense
524.00
20,831.30
12,338.60
24,320.80
78,866.50
20,252.70

About PureTech Health

View Profile
Address
6 Tide Street
Boston Massachusetts 02210
United States
Employees -
Website http://puretechhealth.com/
Updated 07/08/2019
PureTech Health Plc is a cross-disciplinary biopharmacy company, which engages in the development of treatment programs for obesity, cognitive disorders, baldness, depression, allergy, and autoimmune. It operates through the following segments: Growth Stage Affiliates, Project Phase Programmes, Independent Affiliate Programmes, and Parent Company and Other. The Growth Stage Affiliates segment focuses on the development on products to solve major healthcare problems in varied markets.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.